20-46126219-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001250.6(CD40):c.498-421A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.20 ( 1156 hom., cov: 18)
Consequence
CD40
NM_001250.6 intron
NM_001250.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.725
Publications
6 publications found
Genes affected
CD40 (HGNC:11919): (CD40 molecule) This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3). Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2014]
CD40 Gene-Disease associations (from GenCC):
- hyper-IgM syndrome type 3Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.374 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001250.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CD40 | NM_001250.6 | MANE Select | c.498-421A>G | intron | N/A | NP_001241.1 | |||
| CD40 | NM_001322421.2 | c.498-421A>G | intron | N/A | NP_001309350.1 | ||||
| CD40 | NM_001302753.2 | c.498-421A>G | intron | N/A | NP_001289682.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CD40 | ENST00000372285.8 | TSL:1 MANE Select | c.498-421A>G | intron | N/A | ENSP00000361359.3 | |||
| CD40 | ENST00000372276.7 | TSL:1 | c.498-1919A>G | intron | N/A | ENSP00000361350.3 | |||
| CD40 | ENST00000466205.5 | TSL:1 | n.398-421A>G | intron | N/A | ENSP00000434825.1 |
Frequencies
GnomAD3 genomes AF: 0.197 AC: 16682AN: 84780Hom.: 1153 Cov.: 18 show subpopulations
GnomAD3 genomes
AF:
AC:
16682
AN:
84780
Hom.:
Cov.:
18
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.197 AC: 16689AN: 84850Hom.: 1156 Cov.: 18 AF XY: 0.203 AC XY: 8273AN XY: 40680 show subpopulations
GnomAD4 genome
AF:
AC:
16689
AN:
84850
Hom.:
Cov.:
18
AF XY:
AC XY:
8273
AN XY:
40680
show subpopulations
African (AFR)
AF:
AC:
1646
AN:
19830
American (AMR)
AF:
AC:
1411
AN:
7622
Ashkenazi Jewish (ASJ)
AF:
AC:
400
AN:
2100
East Asian (EAS)
AF:
AC:
1345
AN:
3498
South Asian (SAS)
AF:
AC:
1144
AN:
2910
European-Finnish (FIN)
AF:
AC:
1498
AN:
5272
Middle Eastern (MID)
AF:
AC:
55
AN:
180
European-Non Finnish (NFE)
AF:
AC:
8753
AN:
41696
Other (OTH)
AF:
AC:
225
AN:
1158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
663
1326
1990
2653
3316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.